Mocetinostat: Phase II started

Mirati said the Memorial Sloan Kettering Cancer Center began an open-label, U.S. Phase II trial

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE